Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Milad Ashrafizadeh

Showing results (1-10 of 267) with videos related to

Pageof 27
Sort By:
Journal of Basic and Clinical Physiology and Pharmacology|July 9, 2025
<b>Therapeutic potential of</b> r<b>esveratrol:</b> n<b>ovel</b> b<b>iological and</b> p<b>harmacological</b> p<b>erspectives</b>Milad Ashrafizadeh
Gene|May 30, 2026
c-Myc as a vulnerable target in cancer drug resistanceMilad Ashrafizadeh
Fundamental & Clinical Pharmacology|July 9, 2019
Melatonin as a potential modulator of Nrf2Zahra Ahmadi, Milad Ashrafizadeh
Phytotherapy Research : PTR|January 24, 2020
MicroRNAs as novel targets of sulforaphane in cancer therapy: The beginning of a new tale?Hossein Rafiei, Milad Ashrafizadeh, Zahra Ahmadi
Anti-Cancer Agents in Medicinal Chemistry|February 5, 2020
Therapeutic Effects of Curcumin against Bladder Cancer: A Review of Possible Molecular PathwaysMilad Ashrafizadeh, Habib Yaribeygi, Amirhossein Sahebkar
International Journal of Biological Macromolecules|January 19, 2024
Biomedical application of metal-organic frameworks (MOFs) in cancer therapy: Stimuli-responsive and biomimetic nanocomposites in targeted delivery, phototherapy and diagnosisBeixu Li, Milad Ashrafizadeh, Taiwei Jiao
Biological Trace Element Research|December 2, 2019
Back to Nucleus: Combating with Cadmium Toxicity Using Nrf2 Signaling Pathway as a Promising Therapeutic TargetMilad Ashrafizadeh, Zahra Ahmadi, Tahereh Farkhondeh, et al.
Current Cancer Drug Targets|October 29, 2019
Anti-tumor Activity of Propofol: A Focus on MicroRNAsMilad Ashrafizadeh, Zahra Ahmadi, Tahereh Farkhondeh, et al.
Anti-Cancer Agents in Medicinal Chemistry|September 29, 2020
Protective Effect of Resveratrol against Glioblastoma: A ReviewMilad Ashrafizadeh, Reza Mohammadinejad, Tahereh Farkhondeh, et al.
Journal of Pharmaceutical Analysis|July 30, 2025
pH-responsive biomimetic zeolitic imidazolate framework-based nanoparticles for co-delivery of cetuximab and siRNA in synergistic therapy of laryngeal squamous cell carcinomaLiyin Wang, Milad Ashrafizadeh, Gautam Sethi, et al.
Pageof 27

Showing results (1-10 of 267) with videos related to

Sort By:
Pageof 27
Journal of Basic and Clinical Physiology and Pharmacology|July 9, 2025
<b>Therapeutic potential of</b> r<b>esveratrol:</b> n<b>ovel</b> b<b>iological and</b> p<b>harmacological</b> p<b>erspectives</b>Milad Ashrafizadeh
Gene|May 30, 2026
c-Myc as a vulnerable target in cancer drug resistanceMilad Ashrafizadeh
Fundamental & Clinical Pharmacology|July 9, 2019
Melatonin as a potential modulator of Nrf2Zahra Ahmadi, Milad Ashrafizadeh
Phytotherapy Research : PTR|January 24, 2020
MicroRNAs as novel targets of sulforaphane in cancer therapy: The beginning of a new tale?Hossein Rafiei, Milad Ashrafizadeh, Zahra Ahmadi
Anti-Cancer Agents in Medicinal Chemistry|February 5, 2020
Therapeutic Effects of Curcumin against Bladder Cancer: A Review of Possible Molecular PathwaysMilad Ashrafizadeh, Habib Yaribeygi, Amirhossein Sahebkar
International Journal of Biological Macromolecules|January 19, 2024
Biomedical application of metal-organic frameworks (MOFs) in cancer therapy: Stimuli-responsive and biomimetic nanocomposites in targeted delivery, phototherapy and diagnosisBeixu Li, Milad Ashrafizadeh, Taiwei Jiao
Biological Trace Element Research|December 2, 2019
Back to Nucleus: Combating with Cadmium Toxicity Using Nrf2 Signaling Pathway as a Promising Therapeutic TargetMilad Ashrafizadeh, Zahra Ahmadi, Tahereh Farkhondeh, et al.
Current Cancer Drug Targets|October 29, 2019
Anti-tumor Activity of Propofol: A Focus on MicroRNAsMilad Ashrafizadeh, Zahra Ahmadi, Tahereh Farkhondeh, et al.
Anti-Cancer Agents in Medicinal Chemistry|September 29, 2020
Protective Effect of Resveratrol against Glioblastoma: A ReviewMilad Ashrafizadeh, Reza Mohammadinejad, Tahereh Farkhondeh, et al.
Journal of Pharmaceutical Analysis|July 30, 2025
pH-responsive biomimetic zeolitic imidazolate framework-based nanoparticles for co-delivery of cetuximab and siRNA in synergistic therapy of laryngeal squamous cell carcinomaLiyin Wang, Milad Ashrafizadeh, Gautam Sethi, et al.
Pageof 27